George Hebard serves as Executive at ENZON PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, George Hebard has executed 5 insider transactions totaling $457.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 29, 2023 involved purchasing 409,000 shares valued at $376.3K.
George Hebard currently holds 450,000 shares of ENZON PHARMACEUTICALS INC (ENZN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Hebard has been a net buyer of ENZN stock. They have purchased $457.4K and sold $0 worth of shares.
George Hebard's most recent insider trade was on Dec 29, 2023, when they purchased 409,000 shares at $0.92 per share.
Get notified when new Form 4 filings are submitted
| $15.59 |
| Discretionary |
| Nov 7, 2012 | ENZN | $0 | Award | 24,500 | $N/A | Discretionary |
| Jun 20, 2012 | ENZN | $34.4K | Purchase | 5,000 | $6.88 | Discretionary |
| Feb 27, 2012 | ENZN | $0 | Award | 13,737 | $N/A | Discretionary |